Literature DB >> 15060200

Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence.

Suzanne M Mone1, Matthew W Gillman, Tracie L Miller, Eugene H Herman, Steven E Lipshultz.   

Abstract

Exposures to drugs, chemical and biological agents, therapeutic radiation, and other factors before and after birth can lead to pediatric or adult cardiovascular anomalies. Furthermore, nutritional deficiencies in the perinatal period can cause cardiovascular anomalies. These anomalies may affect heart structure, the conduction system, the myocardium, blood pressure, or cholesterol metabolism. Developmental periods before and after birth are associated with different types of risks. The embryonic period is the critical window of vulnerability for congenital malformations. The fetal period seems to have lifelong effects on coronary heart disease and its precursors. During the weeks immediately after birth, susceptibility to myocardial damage seems to be high. Exposure to cancer chemotherapy or radiotherapy in childhood raises the risk of long-term progressive left ventricular dysfunction and other cardiovascular problems. In childhood and adolescence, use of recreational drugs such as cocaine and tobacco poses cardiovascular dangers as well. Where evidence about environmental exposures is limited, we have included models of disease and other exposures that are suggestive of the potential impact of environmental exposures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060200

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  42 in total

1.  Chronic prenatal hypoxia induces epigenetic programming of PKC{epsilon} gene repression in rat hearts.

Authors:  Andrew J Patterson; Man Chen; Qin Xue; Daliao Xiao; Lubo Zhang
Journal:  Circ Res       Date:  2010-06-10       Impact factor: 17.367

Review 2.  Epigenetic mechanisms in developmental programming of adult disease.

Authors:  Man Chen; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-16       Impact factor: 7.851

3.  Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study.

Authors:  Chao-Hua Chuang; Pat Doyle; Jung-Der Wang; Pei-Jen Chang; Jung-Nien Lai; Pau-Chung Chen
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

4.  Prenatal cocaine exposure increases heart susceptibility to ischaemia-reperfusion injury in adult male but not female rats.

Authors:  Soochan Bae; Raymond D Gilbert; Charles A Ducsay; Lubo Zhang
Journal:  J Physiol       Date:  2005-01-27       Impact factor: 5.182

5.  Foetal hypoxia increases cardiac AT(2)R expression and subsequent vulnerability to adult ischaemic injury.

Authors:  Qin Xue; Chiranjib Dasgupta; Man Chen; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2010-09-23       Impact factor: 10.787

Review 6.  Environmental epigenetics and asthma: current concepts and call for studies.

Authors:  Rachel L Miller; Shuk-Mei Ho
Journal:  Am J Respir Crit Care Med       Date:  2008-01-10       Impact factor: 21.405

7.  Multimodality optical imaging of embryonic heart microstructure.

Authors:  Ronit Yelin; Dvir Yelin; Wang-Yuhl Oh; Seok H Yun; Caroline Boudoux; Benjamin J Vakoc; Brett E Bouma; Guillermo J Tearney
Journal:  J Biomed Opt       Date:  2007 Nov-Dec       Impact factor: 3.170

8.  Maternal Chlamydia Infection During Pregnancy and Risk of Cyanotic Congenital Heart Defects in the Offspring.

Authors:  Diane Y Dong; José N Binongo; Vijaya Kancherla
Journal:  Matern Child Health J       Date:  2016-01

Review 9.  Potential effects of environmental chemical contamination in congenital heart disease.

Authors:  Francesca Gorini; Enrico Chiappa; Luna Gargani; Eugenio Picano
Journal:  Pediatr Cardiol       Date:  2014-01-23       Impact factor: 1.655

Review 10.  Short- and long-term adverse effects of cocaine abuse during pregnancy on the heart development.

Authors:  Kurt D Meyer; Lubo Zhang
Journal:  Ther Adv Cardiovasc Dis       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.